Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBD.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
27 May 2019
Historique:
received: 28 06 2018
revised: 28 10 2018
accepted: 12 12 2018
pubmed: 19 12 2018
medline: 24 12 2019
entrez: 19 12 2018
Statut: ppublish

Résumé

Inflammatory bowel disease [IBD] can impair patients' functional capacity with significant negative effects on their quality of life. Our aim was to determine the impact of IBD diagnosis on fitness levels and to assess the levels of engagement in physical activity and fatigue in IBD patient before and after diagnosis. A prospective multi-centre cross-sectional study was performed. Patients diagnosed with IBD in the previous 18 months were recruited. Inclusion criteria included clinical remission and/or no treatment changes within the previous 6 months. Physical exercise levels were assessed by the Godin score and fatigue levels was assessed by the functional assessment of chronic illness therapy [FACIT] score. In total, 158 patients (100 Crohn's disease [CD]) were recruited. Mean age was 35.1 years (95% confidence interval [CI] ± 2.0). Gender distribution was approximately equal [51.3% male]. The Mean Harvey Bradshaw and Simple Clinical Colitis Activity indices were 2.25 [95% CI ± 0.40] and 1.64 [95% CI ± 0.49], respectively. The mean Godin score difference before and after IBD diagnosis was 6.94 [p = 0.002]. Patients with ulcerative colitis [UC] [41.8%] were more likely than patients with CD [23.0%] to reduce their exercise levels [p = 0.04]. FACIT scores were lower in patients who had experienced relapses [p = 0.012] and had severe disease [p = 0.011]. Approximately one-third of patients reduced their activity level following IBD diagnosis. Patients were significantly less physically active after a diagnosis of IBD and this was more apparent in UC. Identification of the risk factors associated with loss of fitness levels would help to address the reduced patient quality of life.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Inflammatory bowel disease [IBD] can impair patients' functional capacity with significant negative effects on their quality of life. Our aim was to determine the impact of IBD diagnosis on fitness levels and to assess the levels of engagement in physical activity and fatigue in IBD patient before and after diagnosis.
METHODS METHODS
A prospective multi-centre cross-sectional study was performed. Patients diagnosed with IBD in the previous 18 months were recruited. Inclusion criteria included clinical remission and/or no treatment changes within the previous 6 months. Physical exercise levels were assessed by the Godin score and fatigue levels was assessed by the functional assessment of chronic illness therapy [FACIT] score.
RESULTS RESULTS
In total, 158 patients (100 Crohn's disease [CD]) were recruited. Mean age was 35.1 years (95% confidence interval [CI] ± 2.0). Gender distribution was approximately equal [51.3% male]. The Mean Harvey Bradshaw and Simple Clinical Colitis Activity indices were 2.25 [95% CI ± 0.40] and 1.64 [95% CI ± 0.49], respectively. The mean Godin score difference before and after IBD diagnosis was 6.94 [p = 0.002]. Patients with ulcerative colitis [UC] [41.8%] were more likely than patients with CD [23.0%] to reduce their exercise levels [p = 0.04]. FACIT scores were lower in patients who had experienced relapses [p = 0.012] and had severe disease [p = 0.011]. Approximately one-third of patients reduced their activity level following IBD diagnosis.
CONCLUSIONS CONCLUSIONS
Patients were significantly less physically active after a diagnosis of IBD and this was more apparent in UC. Identification of the risk factors associated with loss of fitness levels would help to address the reduced patient quality of life.

Identifiants

pubmed: 30561568
pii: 5250917
doi: 10.1093/ecco-jcc/jjy214
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

686-692

Informations de copyright

Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

K Gatt (K)

Division of Gastroenterology, Mater Dei Hospital, Malta.

J Schembri (J)

Division of Gastroenterology, Mater Dei Hospital, Malta.

K H Katsanos (KH)

Department of Gastroenterology and Hepatology, Medical School and University Hospital of Ioannina, Greece.

D Christodoulou (D)

Department of Gastroenterology and Hepatology, Medical School and University Hospital of Ioannina, Greece.

K Karmiris (K)

Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece.

U Kopylov (U)

Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.

C Pontas (C)

Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.

I E Koutroubakis (IE)

Department of Gastroenterology, University Hospital Heraklion, Crete, Greece.

K Foteinogiannopoulou (K)

Department of Gastroenterology, University Hospital Heraklion, Crete, Greece.

A Fabian (A)

University of Szeged, First Department of Internal Medicine, Szeged, Hungary.

T Molnar (T)

University of Szeged, First Department of Internal Medicine, Szeged, Hungary.

D Zammit (D)

Division of Gastroenterology, Mater Dei Hospital, Malta.

M Fragaki (M)

Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece.

D Balomenos (D)

Department of Gastroenterology and Hepatology, Medical School and University Hospital of Ioannina, Greece.

N Zingboim (N)

Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.

S Ben Horin (S)

Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.

G J Mantzaris (GJ)

Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.

P Ellul (P)

Division of Gastroenterology, Mater Dei Hospital, Malta.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH